Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
05/2003
05/28/2003EP1100576A4 Synergism of photodynamic and electropermeation effects on cell vitality as a novel cytotoxic agent
05/28/2003CN1420795A Apparatus and method for microporation of biological membranes using thin film tissue interface devices
05/28/2003CN1420788A Improved treatment of neovascularization
05/27/2003US6569846 Photodynamic therapy and diagnosis and in vitro photodynamic killing of viruses and microorganisms
05/27/2003US6569654 Electroactive materials for stimulation of biological activity of stem cells
05/27/2003CA2131168C Decontaminating blood components
05/22/2003WO2002083686A3 Processes for large scale production of tetrapyrroles
05/21/2003EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders
05/21/2003EP1311261A1 Medicaments for chemotherapeutic treatment of disease
05/21/2003EP1192450A4 High energy phototherapeutic agents
05/21/2003EP1146912A4 Method for improved radiation therapy
05/21/2003EP1005369B1 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
05/21/2003CN1419452A Synergistic methods and compositions for treating cancer
05/20/2003US6566517 Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
05/20/2003US6566070 Detecting preferential protein biosynthesis; label nucleotide sequences, mix with translation system, incubate, detct signal from protein
05/20/2003US6566046 Platelet storage media mixture of sodium chloride, sodium citrate, sodium acetate, sodium phosphate ans psoralen
05/20/2003US6565887 Magnetic heating efficiency, alternating frequency; antitumor, anticarcinogenic agents
05/15/2003WO2003040346A2 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
05/15/2003WO2003040175A1 Conjugate for treating by boron neutron capture (bnc) radiation-resistant tumours
05/15/2003WO2003039597A1 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
05/15/2003WO2003039596A1 Photodynamic therapy for the treatment of hair loss
05/15/2003WO2003039478A2 Method and apparatus for the stimulation of hair growth
05/15/2003WO2003039452A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003WO2002062384A3 Reduced fluence rate pdt
05/15/2003WO2002058730A3 Compositions for treatment of ocular neovascularization
05/15/2003WO2002040533A1 Radiosensitivity enhancers in radiotherapy for cancer and nucleic acids and proteins enhancing radiosensitivity
05/15/2003US20030093092 Optically-absorbing nanoparticles for enhanced tissue repair
05/15/2003US20030092982 Microporation of tissue for delivery of bioactive agents
05/15/2003US20030092667 Delivery of therapeutic compositions using ultrasound
05/15/2003US20030091602 Crosslinked polymers; photopolymerization
05/15/2003CA2466880A1 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
05/15/2003CA2466425A1 Photodynamic therapy for the treatment of hair loss
05/15/2003CA2465945A1 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003CA2429147A1 Radiosensitivity enhancers, radiosensitivity-enhancing nucleic acids and proteins in cancer radiotherapy
05/14/2003EP1310460A2 Device and process for liquid treatment
05/14/2003EP1309330A1 Photosensitizers with ligand targeting properties for tumor therapy
05/14/2003EP1309328A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy
05/14/2003EP1309283A2 Accurate optical treatment of an eye's fundus
05/14/2003CN1416900A Polar medicine
05/13/2003US6562316 Drug delivery system with two-step targeting
05/13/2003CA2127114C A composition for the biological stimulation and correction of the phenotype of an organism and a method for treating the same
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037902A1 Separation of regioisomers of metal phthalocyanines
05/08/2003WO2002039953A9 Texaphyrin coordination compounds and uses thereof
05/08/2003WO2002024226A9 Photosensitisers
05/08/2003WO2001082899A9 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
05/08/2003US20030088176 Non-invasive methods for surgery in the vasculature
05/08/2003US20030088092 Water-soluble porphyrin derivatives and methods of their preparation
05/08/2003US20030087947 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photodynamic therapy
05/08/2003US20030087889 Photodynamic therapy of occult age-related macular degeneration
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/07/2003EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins
05/07/2003EP1307241A1 Photodynamic treatment and uv-b irradiation of a thrombocyte suspension
05/07/2003EP1307227A2 Pharmaceutical compositions
05/07/2003EP1307226A2 Vitronectin receptor antagonist pharmaceuticals
05/07/2003EP1263447A4 Optically-active nanoparticles for use in therapeutic and diagnostic methods
05/06/2003US6559183 Nano-emulsion of 5-aminolevulinic acid
05/06/2003US6558698 Microencapsulated bioactive agents and method of making
05/06/2003US6558653 That uses a dye composition and laser energy
05/06/2003US6558650 Enhancement of cellular gallium uptake
05/02/2003EP1306380A1 Novel expanded porphyrins and process for the synthesis thereof
05/02/2003EP1305317A1 Dihydroporphyrin derivatives and their uses
05/02/2003EP1094839B1 Farnesyl protein transferase inhibitors with (in vivo) radiosensitizing properties
05/01/2003WO2003035108A1 Immunopotentiators in thermotherapy for cancer
05/01/2003WO2003035104A2 Compositions and methods for selected tumor treatment
05/01/2003WO2003034975A2 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
05/01/2003WO2002096365A3 Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
05/01/2003WO2002067850A9 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging
05/01/2003US20030083649 Method for reducing or preventing PDT related inflammation
05/01/2003US20030083494 Porphyrins containing multiple carborane cages which selectively accumulate in neoplastic tissue within the irradiation volume; anticancer agents
05/01/2003US20030083324 Photosensitizing ointment
05/01/2003US20030083261 Anticancer agents
05/01/2003US20030082183 Methods and compositions for treatment of ocular neovascularization and neural injury
05/01/2003US20030082105 Selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions
05/01/2003US20030082101 Photodynamic or sonodynamic agents are subjected to light waves or sound waves in the presence of a metal, a reductant, or a chelate
04/2003
04/29/2003US6555663 Prodrugs for selective drug delivery
04/29/2003US6555527 Hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from Panax ginseng
04/29/2003US6554853 Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
04/24/2003WO2003033022A1 Use of oxaziridine derivatives and precursors in the treatment of dermatoses
04/24/2003WO2003032984A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
04/24/2003WO2003032902A2 Tumor targeted photodiagnostic-phototherapeutic agents
04/24/2003WO2003032901A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents
04/24/2003WO2003032900A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
04/24/2003WO2003011265A3 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds
04/24/2003US20030078499 Microporation of tissue for delivery of bioactive agents
04/24/2003US20030078227 Site-directed transfection with ultrasound and cavitation nuclei
04/24/2003US20030077248 Treating cancer with a culture product from a non-naturally occurring antigen-presenting cell; polyclonal antibodies expression
04/24/2003CA2463994A1 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
04/24/2003CA2463911A1 Tumor targeted photodiagnostic-phototherapeutic agents
04/24/2003CA2463906A1 Pathological tissue detection and treatment employing targeted benzoindole optical agents
04/23/2003EP1304120A1 Use of oxaziridine derivatives and precursors for the treatment of dermatoses
04/22/2003US6553254 Administering ribose to energize cells being treated
04/22/2003US6552005 Treating with the adenovirus encoding cytosine deaminase gene and uracil phosphoribosyltranserase gene; administering 5-fluorocytosine; therapy with radiation
04/22/2003US6551618 Compositions and methods for delivery of agents for neuronal regeneration and survival
04/22/2003US6551576 Container with multi-phase composition for use in diagnostic and therapeutic applications
04/22/2003US6551232 Dosimetry for californium-252(252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof
04/17/2003WO2003002156A3 Contrast agents comprising metal particles encapsulated in microspheres for use in medical diagnostic imaging and therapy
04/17/2003WO2002032415A3 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 95